---
figid: PMC7913190__ijms-22-01506-g002
figlink: pmc/articles/PMC7913190/figure/ijms-22-01506-f002/
number: F2
caption: Caspase-11 upregulation occurs as a result of PAMP and/or cytokine signaling
  and can be amplified by complement signaling. TLR signaling—Exogenous PAMPs, such
  as LPS, that signal through TLRs result in MYD88-dependant activation of NF-κB.
  Endocytosed LPS-TLR4 signals through the TRIF adaptor protein, resulting in the
  activation of IRF3 and IRF7 and activation of type I IFNs, which are responsible
  for caspase-11 upregulation downstream of LPS. IL-1β signaling—IL-1β signals through
  the IL-1 receptor complex, which results in MYD88-dependant NF-κB activation and
  Type I IFN signaling. IL-1β-mediated upregulation of caspase-11 is dependent on
  type I IFN-signaling. Type I IFN signaling—IFNα/β, which is also generated following
  LPS and IL-1β stimulation, signals through IFNAR. This results in phosphorylation
  of STAT1/STAT2 and formation of the ISGF3 transcriptional complex, which significantly
  upregulates caspase-11. Caspase-11 upregulation via Type I IFNs, LPS, or IL-1β is
  significantly impaired in Ifnar−/− BMDM, highlighting the importance of IFNAR signaling
  for caspase-11 expression. Type II IFN signaling—IFNγ signals through the IFNGR,
  resulting in the formation of a phospho-STAT1 dimer, which is capable of directly
  upregulating genes, such as caspase-11, which have IFN-stimulatory-gene (ISG) promoter
  sequences. Complement pathway—the complement protein cleavage product, C3a, is modified
  to C3a-desArg by the carboxypeptdidase Cpb1, which is associated with the C3a receptor
  (C3aR). The modified cleavage product then signals through C3aR, resulting in downstream
  activation of the MAPK pathway. This pathway acts to amplify p38 activation downstream
  of TLR4 and IFNAR signaling, boosting caspase-11 expression.
pmcid: PMC7913190
papertitle: Regulation, Activation and Function of Caspase-11 during Health and Disease.
reftext: Aidan Agnew, et al. Int J Mol Sci. 2021 Feb;22(4):1506.
pmc_ranked_result_index: '23115'
pathway_score: 0.9673094
filename: ijms-22-01506-g002.jpg
figtitle: Caspase-11 upregulation occurs as a result of PAMP and/or cytokine signaling
  and can be amplified by complement signaling
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7913190__ijms-22-01506-g002.html
  '@type': Dataset
  description: Caspase-11 upregulation occurs as a result of PAMP and/or cytokine
    signaling and can be amplified by complement signaling. TLR signaling—Exogenous
    PAMPs, such as LPS, that signal through TLRs result in MYD88-dependant activation
    of NF-κB. Endocytosed LPS-TLR4 signals through the TRIF adaptor protein, resulting
    in the activation of IRF3 and IRF7 and activation of type I IFNs, which are responsible
    for caspase-11 upregulation downstream of LPS. IL-1β signaling—IL-1β signals through
    the IL-1 receptor complex, which results in MYD88-dependant NF-κB activation and
    Type I IFN signaling. IL-1β-mediated upregulation of caspase-11 is dependent on
    type I IFN-signaling. Type I IFN signaling—IFNα/β, which is also generated following
    LPS and IL-1β stimulation, signals through IFNAR. This results in phosphorylation
    of STAT1/STAT2 and formation of the ISGF3 transcriptional complex, which significantly
    upregulates caspase-11. Caspase-11 upregulation via Type I IFNs, LPS, or IL-1β
    is significantly impaired in Ifnar−/− BMDM, highlighting the importance of IFNAR
    signaling for caspase-11 expression. Type II IFN signaling—IFNγ signals through
    the IFNGR, resulting in the formation of a phospho-STAT1 dimer, which is capable
    of directly upregulating genes, such as caspase-11, which have IFN-stimulatory-gene
    (ISG) promoter sequences. Complement pathway—the complement protein cleavage product,
    C3a, is modified to C3a-desArg by the carboxypeptdidase Cpb1, which is associated
    with the C3a receptor (C3aR). The modified cleavage product then signals through
    C3aR, resulting in downstream activation of the MAPK pathway. This pathway acts
    to amplify p38 activation downstream of TLR4 and IFNAR signaling, boosting caspase-11
    expression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1A
  - IL1B
  - C3
  - IL18
  - IFNG
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA7
  - IFNA8
  - IFNA17
  - IFNA6
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - IFNB1
  - IL1R1
  - IFNGR1
  - IFNAR2
  - CPB1
  - C3AR1
  - JAK2
  - TYK2
  - MYD88
  - MAL
  - JAK1
  - IRAK4
  - IRAK1
  - TRAF6
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - STAT1
  - STAT2
  - IKBKE
  - TBK1
  - IRF9
  - IKBKG
  - IRF7
  - IRF3
  - IL6
  - TNF
  - NLRP3
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - CHUK
  - IKBKB
  - TRAM
genes:
- word: ILR/IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: ILR/IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: C3
  symbol: C3
  source: hgnc_symbol
  hgnc_symbol: C3
  entrez: '718'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IFNY
  symbol: IFNG
  source: hgnc_symbol
  hgnc_symbol: IFNG
  entrez: '3458'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IFNa/B
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: IFNGR
  symbol: IFNGR
  source: hgnc_prev_symbol
  hgnc_symbol: IFNGR1
  entrez: '3459'
- word: C3a
  symbol: C3a
  source: hgnc_alias_symbol
  hgnc_symbol: C3
  entrez: '718'
- word: IFNAR2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: cpb1
  symbol: CPB1
  source: hgnc_symbol
  hgnc_symbol: CPB1
  entrez: '1360'
- word: C3aR
  symbol: C3AR
  source: hgnc_alias_symbol
  hgnc_symbol: C3AR1
  entrez: '719'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: Mal
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: IRAK1/4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: IRAK1/4
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IRF3/7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IRF3/7
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: IFNB
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IRF3/7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IRF3/7
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IKKA
  symbol: IKKA
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKKB
  symbol: IKKB
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
chemicals:
- word: TRAM
  source: MESH
  identifier: C411671
diseases: []
figid_alias: PMC7913190__F2
redirect_from: /figures/PMC7913190__F2
figtype: Figure
---
